Top section
Top section
High yields and tight senior/sub spread fuel enthusiasm for issuance among investors and issuers
◆ Pair help market to end week on a high note ◆ GSK offers pick-up over peer AstraZeneca ◆ Glencore finds demand at eight years
◆ French borrower takes €1.15bn across two tranches ◆ Balance struck between size and price to keep investors onside ◆ Small concession offered
Data
More articles
More articles
More articles
-
Issuance 34% ahead of last year’s opening week -
◆ Dual tranche deals attract strong peak books ◆ Bumper bid-to-cover ratios ◆ Premiums scarce
-
Sustainable finance chief leaves Nomura for opportunity in fast-growing region enthusiastic to cut emissions
-
Lenders see greater demand for direct lending as slew of Covid refinancings mature
-
Three tranche deals are increasingly common for issuers wanting size and duration
-
This year’s expected surge in IPOs and M&A deals should drive a proliferation of strategic equity derivative transactions, with $2bn of fees up for grabs
Sub-sections
